DSM’s Higher-Potency Lactopeptide Provides an Innovative Heart Health Solution
A world leader in enzyme technology, DSM has utilized advanced enzymatic hydrolysis to release the effectiveness of these bioactive tripeptides to create TensGuard, which has a history of safe use and is GRAS under 21CFR 102.22.
16/11/07 Scientific studies show that milk-derived tripeptides with the bioactive amino acid sequence IPP (isoleucine-proline-proline) can maintain healthy blood pressure in people who have blood pressure in the normal range.
A world leader in enzyme technology, DSM has utilized advanced enzymatic hydrolysis to release the effectiveness of these bioactive tripeptides to create TensGuard, which has a history of safe use and is GRAS under 21CFR 102.22.
Ideal for many types of supplement formulations, TensGuard is today’s highest potency lactotripeptide and is a natural new approach for dietary supplement manufacturers to meet consumers’ growing demand for innovative heart health solutions.
